Keywords: ADR; adverse drug reaction; AGREE; Appraisal of Guidelines for Research and Evaluation; DBP; diastolic blood pressure; FDA; Food and Drug Administration; GWAS; genome-wide association study; MAP; mean arterial pressure; MI; myocardial infarction; NA; not